Pfizer joining other large drug makers in disclosing payments to doctors

"Pfizer Inc. said Monday that it will become the latest drug maker to publicly disclose the payments it makes to doctors, as the industry has come under fresh fire for its undue influence and could face toughened legislation. The New York drug maker follows Eli Lilly & Co., Merck & Co. and GlaxoSmithKline PLC in pledging its commitment to transparency. Pfizer will report all payments to doctors of more than $500 for consulting and speaking arrangements and will also make public the money it pays them to participate in its clinical trials." The piece notes that Congress is considering mandating this type of disclosure, and paints the move on the part of the drug industry as part of an effort to "clean up its image." Read complete story